InMed Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.57-$2.49 |
Market Cap | $7.5M |
Shares Short | 30,769 |
Financials
See moreRevenue (12 Mos) | $4.9M |
Revenue Growth (YoY) | -26.2% |
Gross Profit (12 Mos) | $1.7M |
Diluted EPS | -$2.84 |
News
See moreYahoo Finance • 5 days ago
InMed receives Nasdaq notice over equity requirement
Yahoo Finance • 4 months ago
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
Yahoo Finance • 4 months ago
Halper Sadeh LLC is Investigating Whether D, AVB, INM, EQR are Obtaining Fair Deals for their Shareholders
Yahoo Finance • 4 months ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—D, INM, ESQ, and GDOT
About
CEO | Mr. Eric A. Adams B.S. Chem., M.I.B. |
CFO | Ms. N. Netta Jagpal |
Address | 500 West Georgia Street, Vancouver, BC, Canada, V6B 0M3 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 6 |